HbA1c and Peripheral Sensory Loss in Relation to Diabetic Foot Screening Findings

complications and care needs among people with diabetes. Objectives: To examine associations of HbA1c and peripheral sensory loss with abnormal foot screening findings among Persadia members at PKU Muhammadiyah Gamping Hospital. Methods: This quantitative cross sectional study included 36 participants selected by total sampling. HbA1c measurement, 10 g monofilament examination, and standardized foot observation were performed. HbA1c was categorized as <7% or >/7%. Frequencies, contingency tables, odds ratios with 95% confidence intervals, and two sided Fisher exact tests were analyzed. Results: Twenty seven participants had HbA1c <7%, and 13 had abnormal foot screening findings. Abnormal findings occurred in 4 of 9 participants with HbA1c >/7% and 9 of 27 with HbA1c <7% (OR 1.60; 95% CI 0.34–7.46; p=0.693). Recalculation of the reported sensory loss table yielded OR 3.09 (95% CI 0.71–13.47; p=0.153), although the sensory loss table requires reconciliation with the descriptive neuropathy counts. Conclusions: Neither HbA1c category nor peripheral sensory loss showed a statistically significant association with abnormal foot screening findings. Glycemic monitoring and standardized foot assessment remain complementary components of diabetes care.